Poland’s Majchrzak says he failed drug check

Poland’s Kamil Majchrzak mentioned he had failed a drug check, including that he didn’t knowingly take a banned substance and that the information got here as “the most important shock.”

The 77th-ranked Majchrzak, who gained the Challenger Tour occasion in Busan, South Korea in October and reached the semifinals of an ATP 250 occasion in Pune, India earlier this 12 months, didn’t present additional particulars concerning the banned substance.

The ITIA mentioned on Friday that Majchrzak had supplied samples from tournaments at Sofia in September and Japan and Seoul in October which have been discovered to include three banned substances (SARM S-22, LGD-4033 and PPARδ agonists).

“I’ve some extremely unhappy and tough information to share with everybody. I’ve examined constructive in anti-doping controls throughout October and November 2022,” Majchrzak wrote in a publish on Instagram on Thursday.

“Firstly, I’ve by no means, ever, knowingly taken any banned substance. At this second I do not know what has occurred and that is the most important shock.

“I’ve began probably the most tough combat of my life – the combat to show my innocence and to return to the game I like.”

The ITIA mentioned the participant can request that his B samples are analysed to see in the event that they affirm the A pattern findings.

“Whereas provisionally suspended, he’s ineligible to compete in or attend any sanctioned tennis occasions organised by the governing our bodies of the game,” the ITIA mentioned.